S100A2 and lung carcinoma: Bulk et al., (2009) reported S100A2 overexpression induced migration, invasion and metastasis in lung cancer suggesting a central role for this protein in proliferation pathways, and its potential to serve as a therapeutic target for treatment of inflammation and cancer.